The Association Between Sarcopenia and Diabetes: From Pathophysiology Mechanism to Therapeutic Strategy
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
Diabetes and sarcopenia are emerging as serious public health issues. Sarcopenia, an age-related disorder characterized by loss of skeletal muscle mass and function, is recognized as a new complication in elderly patients with type 2 diabetes mellitus (T2DM). Type 2 diabetes is characterized by insulin resistance, chronic inflammation, accumulation of advanced glycation products and increased oxidative stress, which can negatively affect skeletal muscle mass, strength and function leading to sarcopenia. There is a mutual interrelationship between T2DM and sarcopenia in light of pathophysiology mechanism and long-term outcome. T2DM will accelerate the decline of muscle mass and function, which will in turn lead to glucose metabolism disorders, reduced physical activity and the risk of diabetes. However, the specific mechanism involved has not been thoroughly studied. Therefore, this review aims to explore the pathophysiology and therapeutic strategy related to sarcopenia and diabetes and provide insight for future investigations, which is of great significance for improving the quality of life in the elderly with diabetes and concurrently reducing the incidence of related complications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afy169 · Cited by 13,818 · cited 3×
“It is found that persistent localization switches from subcutaneous to visceral may lead to the ectopic accumulation of adipocytes and lipids in, such as bone marrow, liver, and especially skeletal muscle.(12,27) Compared with healthy elderly individuals, diabetic patients acquire up to 3-folds of the intramuscular fa…”
BackgroundA metagenome-wide association study of gut microbiota in type 2 diabetes
Qin, J., Li, Y., Cai, Z., Li, S., Zhu, J., Zhang, F., Liang, S., Zhang, W., Guan, Y., Shen, D., et al. (2012) · Nature · doi:10.1038/nature11450 · Cited by 6,762
Self-citationMechanisms linking obesity to insulin resistance and type 2 diabetes
Kahn, S. E., Hull, R. L., & Utzschneider, K. M. (2006) · Nature · doi:10.1038/nature05482 · Cited by 5,448 · cited 1×
“A hallmark pathophysiology of diabetes is obesity and ectopic deposition of fat in many insulin target tissues including skeletal muscle.(106) Accumulation of ectopic lipids in skeletal muscle increases the risk of skeletal muscle IR.”
BackgroundSarcopenia in Asia: Consensus Report of the Asian Working Group for Sarcopenia
Chen, L.-K., Liu, L.-K., Woo, J., Assantachai, P., Auyeung, T.-W., Bahyah, K. S., Chou, M.-Y., Chen, L.-Y., Hsu, P.-S., Krairit, O., et al. (2014) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2013.11.025 · Cited by 4,051
Sarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afz046 · Cited by 3,803
Type 2 diabetes as an inflammatory disease
Donath, M. Y., & Shoelson, S. E. (2011) · Nature Reviews Immunology · doi:10.1038/nri2925 · Cited by 3,737
Goodpaster, B. H., Park, S. W., Harris, T. B., Kritchevsky, S. B., Nevitt, M., Schwartz, A. V., Simonsick, E. M., Tylavsky, F. A., Visser, M., Newman, A. B., et al. (2006) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/61.10.1059 · Cited by 3,083
Reactive oxygen species have a causal role in multiple forms of insulin resistance
Houstis, N., Rosen, E. D., & Lander, E. S. (2006) · Nature · doi:10.1038/nature04634 · Cited by 2,525 · cited 2×
“While T2DM is associated with increased oxidative stress,(57) hyperglycemia in T2DM triggers increased production of ROS.(86) ROS activates the ubiquitin-proteasome system and accelerates the degradation of muscle proteins,(87) which leads to sarcopenia.”
BackgroundGenetics of diabetes mellitus and diabetes complications
Cole, J. B., & Florez, J. C. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-020-0278-5 · Cited by 1,797
Regulation of myostatin activity and muscle growth
Lee, S.-J., & McPherron, A. C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151270098 · Cited by 1,616
Visser, M., Pahor, M., Taaffe, D. R., Goodpaster, B. H., Simonsick, E. M., Newman, A. B., Nevitt, M., & Harris, T. B. (2002) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/57.5.m326 · Cited by 1,294
Dent, E., Morley, J. E., Cruz-Jentoft, A. J., Arai, H., Kritchevsky, S. B., Guralnik, J., Bauer, J. M., Pahor, M., Clark, B. C., Cesari, M., et al. (2018) · The Journal of nutrition, health and aging · doi:10.1007/s12603-018-1139-9 · Cited by 1,130 · cited 1×
“The 2018 clinical practice guidelines strongly recommend physical exercise as the primary treatment for sarcopenia.(125)”
MethodSkeletal muscle hypertrophy and atrophy signaling pathways
Glass, D. J. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.04.018 · Cited by 1,106 · cited 1×
“Muscle protein synthesis is mainly regulated by two factors: insulin-like growth factor 1 (IGF1) and myostatin.(61,62) Protein synthesis inhibition is mediated by inhibition of the IGF1-PI3K-Akt-mTOR and SC-Gαi2 pathways.”
BackgroundAge-related and disease-related muscle loss: The effect of diabetes, obesity, and other diseases
Kalyani, R. R., Corriere, M., & Ferrucci, L. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70034-8 · Cited by 1,102 · cited 1×
“mass decreases, IR increases lipolysis, releases free fatty acids (FFA) from adipose tissue, and inhibits the growth hormone (GH)-insulin-like growth factor (IGF1) axis that promotes protein synthesis in skeletal muscle.(66)”
BackgroundKootte, R. S., Levin, E., Salojärvi, J., Smits, L. P., Hartstra, A. V., Udayappan, S. D., Hermes, G., Bouter, K. E., Koopen, A. M., Holst, J. J., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.09.008 · Cited by 1,039 · cited 1×
“Additionally, fecal microbiota transplantation from healthy donors to patients with metabolic syndrome was associated with increased microbial diversity, improved glycemic control, and insulin sensitivity.(117) Recent studies have shown that the gut”
BackgroundInsulin resistance: review of the underlying molecular mechanisms
Yaribeygi, H., Farrokhi, F. R., Butler, A. E., & Sahebkar, A. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.27603 · Cited by 929 · cited 1×
“Skeletal muscle is one of the target organs for insulin action and insulin resistance.(53) Impaired insulin action may promote protein degradation and hamper protein synthesis, resulting in both mass and strength drops of muscle.”
BackgroundAccelerated Loss of Skeletal Muscle Strength in Older Adults With Type 2 Diabetes
Park, S. W., Goodpaster, B. H., Strotmeyer, E. S., Kuller, L. H., Broudeau, R., Kammerer, C., de Rekeneire, N., Harris, T. B., Schwartz, A. V., Tylavsky, F. A., et al. (2007) · Diabetes Care · doi:10.2337/dc06-2537 · Cited by 766
Decreased Muscle Strength and Quality in Older Adults With Type 2 Diabetes
Park, S. W., Goodpaster, B. H., Strotmeyer, E. S., de Rekeneire, N., Harris, T. B., Schwartz, A. V., Tylavsky, F. A., & Newman, A. B. (2006) · Diabetes · doi:10.2337/db05-1183 · Cited by 751
Smith, G. I., Atherton, P., Reeds, D. N., Mohammed, B. S., Rankin, D., Rennie, M. J., & Mittendorfer, B. (2011) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.110.005611 · Cited by 665
Oxidative capacity and ageing in human muscle
Conley, K. E., Jubrias, S. A., & Esselman, P. C. (2000) · The Journal of Physiology · doi:10.1111/j.1469-7793.2000.t01-1-00203.x · Cited by 651
IL-6-induced skeletal muscle atrophy
Haddad, F., Zaldivar, F., Cooper, D. M., & Adams, G. R. (2005) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01026.2004 · Cited by 612
Sarcopenia from mechanism to diagnosis and treatment in liver disease
Dasarathy, S., & Merli, M. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.07.040 · Cited by 608 · cited 1×
“Muscle protein synthesis is mainly regulated by two factors: insulin-like growth factor 1 (IGF1) and myostatin.(61,62) Protein synthesis inhibition is mediated by inhibition of the IGF1-PI3K-Akt-mTOR and SC-Gαi2 pathways.”
BackgroundPrevalence and Determinant Factors of Sarcopenia in Patients With Type 2 Diabetes
Kim, T. N., Park, M. S., Yang, S. J., Yoo, H. J., Kang, H. J., Song, W., Seo, J. A., Kim, S. G., Kim, N. H., Baik, S. H., et al. (2010) · Diabetes Care · doi:10.2337/dc09-2310 · Cited by 585
Pathogenesis and Management of Sarcopenia
Dhillon, R. J. S., & Hasni, S. (2017) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2016.08.002 · Cited by 574 · cited 1×
“Both aerobic and resistance exercise can prevent and treat the decline in muscle mass and strength that occurs with aging.(126) Aerobic exercise decreases the level of HbA1c, fasting blood glucose, and IR, as well improves skeletal muscle mass, especially leg strength.”
BackgroundLong-term metformin use and vitamin B12 deficiency in the Diabetes Prevention Program Outcomes Study
Aroda, V. R., Edelstein, S. L., Goldberg, R. B., Knowler, W. C., Marcovina, S. M., Orchard, T. J., Bray, G. A., Schade, D. S., Temprosa, M. G., White, N. H., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3754 · Cited by 536 · cited 1×
“dysgeusia, hyperoxia, and vitamin b12 deficiency may hamper their prospect widely utilization in these populations.(150) Sulfonylureas predispose to muscle atrophy and should be avoided in patients with sarcopenia or in patients with diabetes at risk of developing sarcopenia.”
BackgroundNair (2005) · doi:10.1093/ajcn/81.5.953 · Cited by 469
Bua, E., Johnson, J., Herbst, A., Delong, B., McKenzie, D., Salamat, S., & Aiken, J. M. (2006) · The American Journal of Human Genetics · doi:10.1086/507132 · Cited by 442 · cited 1×
“Compared with younger generation, the oxidative capacity per muscle unit is reduced by 50% in the elderly,(93) and accompanied by increased incident of mitochondrial DNA mutations.(94) Diabetes-induced mitochondrial dysfunction leads to myocyte apoptosis,(95) thereby increasing the risk of sarcopenia.”
BackgroundGut Microbiota, Muscle Mass and Function in Aging: A Focus on Physical Frailty and Sarcopenia
Ticinesi, A., Nouvenne, A., Cerundolo, N., Catania, P., Prati, B., Tana, C., & Meschi, T. (2019) · Nutrients · doi:10.3390/nu11071633 · Cited by 418 · cited 1×
“Human gut microbiota is able to influence host physiology by regulating multiple processes, including nutrient absorption, inflammation, oxidative stress, immune function, and anabolic balance.(112) Dysbiosis of the gut microbiota plays an important role in the pathogenesis of IR and T2D through multiple mechanisms,(1…”
BackgroundGut Microbiome Fermentation Determines the Efficacy of Exercise for Diabetes Prevention
Liu, Y., Wang, Y., Ni, Y., Cheung, C. K. Y., Lam, K. S. L., Wang, Y., Xia, Z., Ye, D., Guo, J., Tse, M. A., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2019.11.001 · Cited by 405 · cited 1×
“The Therapeutic Strategy for Sarcopenia in T2DM Non-Pharmacological Approaches Physical Exercise Exercise is the most cost-effective lifestyle intervention for the prevention and treatment paradigm of diabetes.(122) Numerous studies have shown that exercise can also retard muscle loss by attenuating the activation of…”
BackgroundChronic low-grade inflammation and age-related sarcopenia
Beyer, I., Mets, T., & Bautmans, I. (2012) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e32834dd297 · Cited by 400 · cited 1×
“Due to the decreased protection mechanism or the other agents, aging is also accompanied by an increase in inflammatory markers and oxidative stress, both of which have been implicated as significant pathophysiological changes in DM and sarcopenia.(31,32) Specifically, mitochondrial dysfunction and advanced glycation…”
BackgroundNutrition and Sarcopenia—What Do We Know?
Ganapathy, A., & Nieves, J. W. (2020) · Nutrients · doi:10.3390/nu12061755 · Cited by 355
Sinha-Hikim, I., Cornford, M., Gaytan, H., Lee, M. L., & Bhasin, S. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0357 · Cited by 318 · cited 1×
“For instance, reduced testosterone levels impaired self-renewal of satellite cell in muscle.(34) It is noteworthy that decline in serum testosterone levels in males with diabetes may be more significant.”
BackgroundThe Future Prevalence of Sarcopenia in Europe: A Claim for Public Health Action
Ethgen, O., Beaudart, C., Buckinx, F., Bruyère, O., & Reginster, J. Y. (2017) · Calcified Tissue International · doi:10.1007/s00223-016-0220-9 · Cited by 280
Development of selective androgen receptor modulators (SARMs)
Narayanan, R., Coss, C. C., & Dalton, J. T. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.06.013 · Cited by 251 · cited 1×
“However, adverse side effects exist, such as dyslipidemia, benign prostatic hypertrophy and uterine hyper-proliferation.(145) Androgens are important for building and maintaining skeletal muscle, and due to their anabolic effects on muscle, they are considered superior in the potential treatment of sarcopenia.”
BackgroundKiecolt-Glaser, J. K., Belury, M. A., Andridge, R., Malarkey, W. B., Hwang, B. S., & Glaser, R. (2012) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.05.011 · Cited by 233 · cited 1×
“Omega-3 supplementation affects muscle directly by increasing muscle protein synthesis(136) and indirectly by reducing systemic inflammation.(137) Opacity, type and dose of Omega-3 supplements are most effective in the prevention and treatment of sarcopenia, thus, more prospective cohort studies are needed.”
BackgroundBuch, A., Carmeli, E., Boker, L. K., Marcus, Y., Shefer, G., Kis, O., Berner, Y., & Stern, N. (2016) · Experimental Gerontology · doi:10.1016/j.exger.2016.01.008 · Cited by 227 · cited 1×
“Increased IR increases ectopic fat accumulation and promotes the production of pro-inflammatory factors that inhibit myogenesis and increase muscle catabolism.(72) In skeletal muscle, insulin binds to the insulin receptor (GLUT4), allowing glucose uptake by the muscle cells.”
BackgroundPapanicolaou, D. A., Ather, S. N., Zhu, H., Zhou, Y., Lutkiewicz, J., Scott, B. B., & Chandler, J. (2013) · The Journal of nutrition, health and aging · doi:10.1007/s12603-013-0335-x · Cited by 196 · cited 2×
“SARMs have an acceptable safety profile and positive effects on body composition and function in clinical trials.(143,146) Hepatotoxicity and off-target effects on genitalia were major treatment-limiting side effects.”
BackgroundSelective Androgen Receptor Modulators: Current Knowledge and Clinical Applications
Solomon, Z. J., Mirabal, J. R., Mazur, D. J., Kohn, T. P., Lipshultz, L. I., & Pastuszak, A. W. (2019) · Sexual Medicine Reviews · doi:10.1016/j.sxmr.2018.09.006 · Cited by 174 · cited 1×
“Hepatotoxicity and off-target effects on genitalia were major treatment-limiting side effects.(147) Nonetheless, even if”
BackgroundSystemic Inflammation Predicts All-Cause Mortality: A Glasgow Inflammation Outcome Study
Proctor, M. J., McMillan, D. C., Horgan, P. G., Fletcher, C. D., Talwar, D., & Morrison, D. S. (2015) · PLOS ONE · doi:10.1371/journal.pone.0116206 · Cited by 168 · cited 1×
“Due to the decreased protection mechanism or the other agents, aging is also accompanied by an increase in inflammatory markers and oxidative stress, both of which have been implicated as significant pathophysiological changes in DM and sarcopenia.(31,32) Specifically, mitochondrial dysfunction and advanced glycation…”
BackgroundShang, X., Scott, D., Hodge, A. M., English, D. R., Giles, G. G., Ebeling, P. R., & Sanders, K. M. (2016) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.116.140954 · Cited by 137
Abbatecola, A. M., Paolisso, G., Fattoretti, P., Evans, W. J., Fiore, V., Dicioccio, L., & Lattanzio, F. (2011) · The Journal of nutrition, health and aging · doi:10.1007/s12603-011-0366-0 · Cited by 137
Liu, H.-W., & Chang, S.-J. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00636 · Cited by 113 · cited 3×
“Numerous studies have shown that exercise can also retard muscle loss by attenuating the activation of NF-κB.(123,124) The 2018 clinical practice guidelines strongly recommend physical exercise as the primary treatment for sarcopenia.”
BackgroundGut microbiome catabolites as novel modulators of muscle cell glucose metabolism
Houghton, M. J., Kerimi, A., Mouly, V., Tumova, S., & Williamson, G. (2019) · The FASEB Journal · doi:10.1096/fj.201801209r · Cited by 92
Myosteatosis: a relevant, yet poorly explored element of sarcopenia
Zamboni, M., Gattazzo, S., & Rossi, A. P. (2019) · European Geriatric Medicine · doi:10.1007/s41999-018-0134-3 · Cited by 75
Neto, W. K., Gama, E. F., Rocha, L. Y., Ramos, C. C., Taets, W., Scapini, K. B., Ferreira, J. B., Rodrigues, B., & Caperuto, É. (2015) · AGE · doi:10.1007/s11357-014-9742-0 · Cited by 64 · cited 1×
“Transdermal testosterone gel increases the blood concentration of androgens, which has a favorable anabolic effect on skeletal muscle.(144) However, adverse side effects exist, such as dyslipidemia, benign prostatic hypertrophy and uterine hyper-proliferation.”
BackgroundMele, A., Calzolaro, S., Cannone, G., Cetrone, M., Conte, D., & Tricarico, D. (2014) · Pharmacology Research & Perspectives · doi:10.1002/prp2.28 · Cited by 58
Omura, T., & Araki, A. (2022) · Geriatrics & Gerontology International · doi:10.1111/ggi.14339 · Cited by 47
Cited by
Wang, Y., Lan, B., Zhang, S., Mu, Y., Mi, J., Yu, J., Zhan, Q., Luo, B., Lin, F., Teng, J., et al. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-01877-4 · Cited by 8
“Aging causes skeletal muscle to degenerate into sarcopenia, and diabetes accelerates this process through multiple mechanisms [6].”
Metadata
- Authors
- Chen, H., Huang, X., Dong, M., Wen, S., Zhou, L., & Yuan, X.
- Venue
- Diabetes, Metabolic Syndrome and Obesity
- Publisher
- Informa UK Limited
- Published
- 2023-05
- Volume
- Volume 16
- Pages
- 1541-1554
- ISSN
- 1178-7007 (ISSN-L)
- OpenAlex
- W4379508080
- Cited by
- 159
- References
- 48
- FWCI
- 23.02
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.